Data on PolyMedix's Novel Antibiotics Presented at the 40th Annual Meeting of the Ocular Microbiology and Immunology Group
13th Nov 2006, 16:41 GMT
PolyMedix, an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, announced that pre-clinical data on the potential uses of the company's compounds for ophthalmic infections were presented at the 40th Annual Meeting of the Ocular Microbiology and Immunology Group in Las Vegas, NV.
Data on PolyMedix's Novel Antibiotics Presented at the 40th Annual Meeting of the Ocular Microbiology and Immunology Group related news:
- Research Findings In Allergy-Immunology Unveiled — Health News from Medical News Today
- Allergy And Immunology On The Cusp Of Major Breakthroughs — Health News from Medical News Today
- ORENCIA Data Demonstrated Improvement in Children and Adolescents With Juvenile Idiopathic Arthritis as Measured by the Validated ACR Pediatric Criteria — StratWire - Business of Healthcare NewsFeed
- 12 Studies Evaluating Cytyc's MammoSite Radiation Therapy System Presented at ASTRO Annual Meeting — Nuclear Medicine News from StratCenter.com
- Long-Term Data Shows No Increase In Cancer Cases From Biologic Therapy — Health News from Medical News Today
- New Data on Otsuka's Investigational Product for Hyponatremia Presented at American Heart Assoc Annual Meeting — Pharmaceuticals News from StratCenter.com
- Allergists Explore Rising Prevalence And Unmet Needs Attributed To Allergic Rhinitis — Health News from Medical News Today
- Impact Of Rheumatoid Arthritis Goes Beyond Signs And Symptoms, Delay In Treatment May Impact Long-Term Employment — Health News from Medical News Today
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data — EurekAlert! - Medicine and Health
- [Microbiology] Combinatorial biosynthesis of novel antibiotics related to daptomycin — Proceedings of the National Academy of Sciences recent issues
Latest news from Pharmaceuticals News from StratCenter.com:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection
- Medco to Present at the Credit Suisse Annual Healthcare Conference
- Bob Dole Medicare Podcast Helps Seniors through 2007 Drug Coverage Enrollment Process
- Unique Sugar Improves Energy, Pain and Quality of Life in Fibromyalgia and Chronic Fatigue Patients!
- Care Clinic Purchases Pinnacle Easy Care
- Pegasystems Enhances 2 Business Critical BPM Frameworks for the Healthcare Industry
- Isis Cholesterol Drug Shown Effective
- Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
- Nymox Reports Q3 2006 Financial Results
- RemoteMDx Raises $6 mln in Private Placement